Activest Wealth Management’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
PCH
SCM
FLAM
O
DCM
AC
Activest Wealth Management's NPCE Position: Q2 2026 in Review
Activest Wealth Management sold out of Neuropace (NPCE) in Q2 2026, closing a stake of 125 shares — an estimated $1.64K sold.
Activest Wealth Management first reported a position in NPCE in Q1 2026 and held it in 1 quarter. The position peaked at $1.64K in Q1 2026. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.
- Activest Wealth Management reported no remaining Neuropace position as of Q2 2026 after selling out during the quarter.
- Activest Wealth Management sold 125 Neuropace shares in Q2 2026, an estimated $1.64K.
- Activest Wealth Management first reported a position in Neuropace in Q1 2026 and held it in 1 quarter.
- Activest Wealth Management's Neuropace position peaked at $1.64K in Q1 2026.
- 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.
Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.